Publication | Open Access
PIK3C2G copy number is associated with clinical outcomes of colorectal cancer patients treated with oxaliplatin.
17
Citations
17
References
2015
Year
PIK3C2G is capable of predicting the recurrence and overall survival of stage III CRC patients receiving oxaliplatin-based therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1